Discover Weakness Deemed Unwarranted and 4 Stock Analyses to Know Now
January 29, 2013
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX): Current Price: $8.10
The company’s price target has been increased to $15 by Brean Capital due to positive Ph III Zerenex data. The stock has a Buy rating.
Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Wall St. Cheat Sheet has been featured in these fine media outlets:
